HomeOpen Access NewsClinical Trials

Clinical Trials

Subscribe to Updates

Cambridge scientists find gut bacteria can remove toxic PFAS from the body

Diseases & Conditions
Cambridge scientists discover that certain gut bacteria can absorb and eliminate PFAS, toxic 'forever chemicals' linked to health risks.

The Californian COVID mutation is more infectious

Research & Innovation
The Californian COVID mutation appears to be as infectious as the UK or South African mutations - but does it have the potential to be more deadly?

FDA reveals that Johnson & Johnson vaccine is 86% effective

Research & Innovation
New documents from the FDA show that the Johnson & Johnson vaccine appears to be 86% effective against COVID-19 - signalling that it will soon be approved in the US.

Pfizer vaccine can reduce COVID hospitalisation and death by 75%

Health & Social Care
Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.

Hong Kong approves the Sinovac COVID vaccine for use

Health & Social Care
The Sinovac COVID vaccine was revealed to be working at 50.4% efficacy by the Butantan Institute last month, but new data suggests that this could actually be 62%.

Can an mRNA vaccine be used to cure some types of cancer?

Research & Innovation
COVID brought the idea of mRNA vaccines to the attention of the world - now, cancer researchers are investigating how a similar vaccine could stop tumours in a single treatment.

Pfizer vaccine can still prevent death from the South African mutation

Health & Social Care
The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.

REACT study: COVID cases in hospitals “higher than at the peak of the first wave”

Health & Social Care
New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.

The Johnson & Johnson COVID vaccine works with just one dose

Health & Social Care
The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.

Existing drugs could be used to fight COVID-19 in elderly patients

Research & Innovation
A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.

What are the side effects of the AstraZeneca vaccine?

Health & Social Care
Here, we use science to dissect some of the rumours about the side effects of the AstraZeneca and Oxford University vaccine.

WHO recommends use of AstraZeneca vaccine for all age groups

Health & Social Care
The World Health Organisation have suggested that the Oxford and AstraZeneca vaccine can be safely used for all age groups, including those aged 65 and over.

AstraZeneca vaccine cannot stop the South African mutation

Health & Social Care
The new results led to the South African Government suspending use of AstraZeneca in their vaccination programme, as it is no longer able to stop the mutation - but could still prevent hospitalisation and fatality.

Sputnik V vaccine is 91.6% effective against COVID

Research & Innovation
Interim data from Phase 3 clinical trials show that Russia's Sputnik V vaccine is capable of a 91.6% efficacy against COVID-19.

The EU authorises AstraZeneca COVID vaccine for use

Health & Social Care
European regulators have approved their third vaccine, AstraZeneca - which comes after a week of tense communications between the two parties.

Novavax vaccine is 85.6% efficient against UK COVID mutation

Health & Social Care
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.

European Commission will get 60% less AstraZeneca vaccines

Health & Social Care
EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.
1234Page 7 of 4

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd